115 related articles for article (PubMed ID: 3072292)
21. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.
Forbes RD; Parfrey NA; Gomersall M; Darden AG; Guttmann RD
J Exp Med; 1986 Oct; 164(4):1239-58. PubMed ID: 3531383
[TBL] [Abstract][Full Text] [Related]
22. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts.
Klempnauer J; Steiniger B
Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182
[No Abstract] [Full Text] [Related]
23. Failure to prolong rat renal allograft survival time by photochemical donor kidney pretreatment during hypothermic pulsatile kidney preservation.
Oesterwitz H; Kaden J; Schneider W; Fritsch W
Urol Res; 1988; 16(1):53-5. PubMed ID: 3278479
[TBL] [Abstract][Full Text] [Related]
24. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
Pollak R; Blanchard JM
Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
[TBL] [Abstract][Full Text] [Related]
25. Increase of major histocompatibility complex class II--positive cells in cardiac allografts by interferon-gamma has no impact on graft survival.
Ijzermans JN; Bouwman E; van der Meide PH; Jeekel J; Marquet RL
Transplantation; 1989 Dec; 48(6):1039-41. PubMed ID: 2512699
[TBL] [Abstract][Full Text] [Related]
26. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts.
Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ
Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818
[No Abstract] [Full Text] [Related]
27. Absence of class II major histocompatibility complex antigen induction in cyclosporine A--treated recipients of heart and kidney allografts in the rat.
Milton AD; Spencer SC; Fabre JW
Transplant Proc; 1987 Feb; 19(1 Pt 1):192-4. PubMed ID: 3152686
[No Abstract] [Full Text] [Related]
28. Combination of cyclosporine and splenectomy suppresses interleukin-6 production and major histocompatibility complex class II expression and prolongs cardiac xenograft survival.
Peterson SM; Strzalka CT; Johnkoski JA; Noble B; Gorfien J; Hoover EL; Bergsland J
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1001-5. PubMed ID: 8159020
[TBL] [Abstract][Full Text] [Related]
29. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation.
Sell KW; Tadros T; Wang YC; Hertzler G; Knopf WD; Murphy DA; Ahmed-Ansari A
J Heart Transplant; 1988; 7(6):407-18. PubMed ID: 2463352
[TBL] [Abstract][Full Text] [Related]
30. Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content.
Tyerman K; Barron PT; Da Costa M; McCleish M; Fulford A; Collier SJ; Thiru S
Transplant Proc; 1990 Oct; 22(5):2325. PubMed ID: 2219389
[No Abstract] [Full Text] [Related]
31. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
32. Different patterns of donor MHC antigen induction in rat kidney allografts following active and passive enhancement.
Priestley CA; Fabre JW
Transplantation; 1989 Aug; 48(2):275-80. PubMed ID: 2667211
[TBL] [Abstract][Full Text] [Related]
33. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
34. Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.
Pêche H; van Denderen B; Roussel JC; Trinité B; Soulillou JP; Cuturi MC
Transplantation; 2004 Mar; 77(5):733-40. PubMed ID: 15021837
[TBL] [Abstract][Full Text] [Related]
35. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
[TBL] [Abstract][Full Text] [Related]
36. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells.
Ferry B; Halttunen J; Leszczynski D; Schellekens H; vd Meide PH; Häyry P
Transplantation; 1987 Oct; 44(4):499-503. PubMed ID: 3118519
[TBL] [Abstract][Full Text] [Related]
37. Prolonged survival of class II transactivator-deficient cardiac allografts.
June Brickey W; Felix NJ; Griffiths R; Zhang J; Wang B; Piskurich JF; Itoh-Lindstrom Y; Coffman TM; Ting JP
Transplantation; 2002 Nov; 74(9):1341-8. PubMed ID: 12451276
[TBL] [Abstract][Full Text] [Related]
38. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
[No Abstract] [Full Text] [Related]
39. PUVA augments cyclosporine A-mediated rat cardiac allograft survival.
Horvath KA; Granstein RD
J Surg Res; 1992 Jun; 52(6):565-70. PubMed ID: 1528032
[TBL] [Abstract][Full Text] [Related]
40. Depletion of donor kidney dendritic cells prolongs graft survival.
McKenzie JL; Beard ME; Hart DN
Transplant Proc; 1984 Aug; 16(4):948-51. PubMed ID: 6380059
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
